ATLASMatinas BioPharma (MTNB) earnings date: Nov 9, 2026
Matinas BioPharma (MTNB) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on MTNB
| Last price | $1.28 (-15.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±9.2% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 3 reports |
These figures come from the same calibrated model and valuation as the Matinas BioPharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Matinas BioPharma reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Matinas BioPharma. You can switch it off at any time.
Alert me before MTNB reportsFree to start. Creating an account takes under a minute.
Notify me when Matinas BioPharma reports
Track MTNB free Add Matinas BioPharma to a free ATLAS watchlist and see its next report date in one place.
MTNB earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Jul 9, 2026 · Miss |
| Beat rate (last 3 reports) | 1 of 3 (33%) |
| Average EPS surprise | -48.7% |
| Average move around a report | ±12.2% (last 3) |
| Sector | Healthcare · Biotechnology |
Matinas BioPharma earnings history: last 3 reports
Matinas BioPharma last reported on Jul 9, 2026: EPS of -$0.02 against an estimate of $0.04 (-150.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 9, 2026 | $0.04 | -$0.02 | -150.0% | Miss | +22.6% |
| Feb 12, 2026 | $1.03 | $1.07 | +3.9% | Beat | -4.7% |
| Oct 27, 2025 | $0.54 | $0.54 | 0.0% | In line | -9.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for MTNB
See the fair value, the probability range and the earnings history of Matinas BioPharma on its ATLAS page.
Matinas BioPharma (MTNB) stock analysisPlans from €3.99 a month.
Matinas BioPharma earnings: frequently asked questions
When does Matinas BioPharma (MTNB) report earnings?
Matinas BioPharma is scheduled to report on Monday, November 9, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does MTNB beat earnings estimates?
Of its last 3 reports with a recorded result, Matinas BioPharma beat the EPS estimate 1 times; the average surprise was -48.7%. Past results do not predict the next one.
How much does MTNB move around earnings?
Over its last 3 reports the stock moved an average of 12.2% (absolute, from the close before the report day to the close after it), and finished higher 1 of 3 times.
Did Matinas BioPharma beat earnings estimates last quarter?
Matinas BioPharma last reported on Jul 9, 2026: EPS of -$0.02 against an estimate of $0.04 (-150.0% surprise), a miss.
How much does MTNB usually move in a day?
On a normal trading day the ATLAS model puts MTNB’s one-day range at about ±9.2%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer